Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Molecular Cell|August 4, 2006
Rad17 phosphorylation is required for claspin recruitment and Chk1 activation in response to replication stressXin Wang, Lee Zou, Tao Lu, et al.
Molecular Cancer Therapeutics|May 19, 2011
Development and characterization of a potent immunoconjugate targeting the Fn14 receptor on solid tumor cellsHong Zhou, John W Marks, Walter N Hittelman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2009
Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bedOliver Riesterer, Kathryn A Mason, Uma Raju, et al.
Cancer Research|June 1, 2013
Antitumor activity of a humanized, bivalent immunotoxin targeting fn14-positive solid tumorsHong Zhou, Walter N Hittelman, Hideo Yagita, et al.
Molecular Cancer Therapeutics|September 11, 2019
CNDAC-Induced DNA Double-Strand Breaks Cause Aberrant Mitosis Prior to Cell DeathXiaojun Liu, Yingjun Jiang, Kei-Ichi Takata, et al.
Molecular Cancer Therapeutics|February 3, 2007
The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMAMi-Ae Lyu, Lawrence H Cheung, Walter N Hittelman, et al.
The Journal of Biological Chemistry|May 12, 2011
RING finger and WD repeat domain 3 (RFWD3) associates with replication protein A (RPA) and facilitates RPA-mediated DNA damage responseShangfeng Liu, Jessica Chu, Nur Yucer, et al.
Cancer Letters|March 6, 2012
Bax345/BLyS: a novel, completely human fusion protein targeting malignant B cells and delivering a unique mitochondrial toxinMi-Ae Lyu, Lawrence H Cheung, Walter N Hittelman, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 1, 2019
Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme BLawrence H Cheung, Yunli Zhao, Ana Alvarez-Cienfuegos, et al.
Anesthesia and Analgesia|March 7, 2012
Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor systemMohamed Naguib, Jijun J Xu, Philippe Diaz, et al.
Pageof 7